Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-17

Clinical Trial Update: Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) [NA]

View source ↗

Summary

A clinical trial (ASCENT) evaluating adipose stem cell mitochondria supplementation to oocytes is currently recruiting for infertility-related indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASCENT Adipose Stem Cell Mitochondria Supplementation

Snippet

Sponsor: Sunkaky Medical Cooperation | Conditions: Female Infertility, Oocyte Competence | NA | Status: RECRUITING